Clinical studies recruiting near Edegem

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site BE32001 · Astellas Pharma Global Development, Inc. · NCT05970172 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Universitair Ziekenhuis Antwerpen (UZA) · Travere Therapeutics, Inc. · NCT06247085 Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
Phase 3 · Antwerp University Hospital · Lakefront Biotherapeutics NV · NCT06652633 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Universitair Ziekenhuis Antwerpen · Amgen · NCT07037433 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Antwerp University Hospital ( Site 0407) · Merck Sharp & Dohme LLC · NCT07216703 A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Universitair Ziekenhuis Antwerpen (UZA) · Alimentiv Inc. · NCT07363044 Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Phase 1/Phase 2 · Antwerp University Hospital · OSE Immunotherapeutics · NCT05751798 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Antwerp University Hospital · Eli Lilly and Company · NCT06890598 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · UZ Antwerpen - Pediatric Cardiology · Bayer · NCT07192952 Effect of IMT in Patients After Acute Exacerbations of COPD
NA · Universitair Ziekenhuis Antwerpen · KU Leuven · NCT07213128 A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People and Patients With Metabolic Dysfu
Phase 1 · SGS Life Science Services - Clinical Research · Boehringer Ingelheim · NCT06575400 Visualization of Inspiratory Effort and Respiratory Mechanics to Promote Lung- and Diaphragm Protective Ventilation
NA · Antwerp University Hospital (UZA) · University Hospital, Antwerp · NCT05459116 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Antwerp University Hospital · Eli Lilly and Company · NCT07222332 A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio
Phase 1 · SGS Belgium NV - Clinical Pharmacology Unit · Debiopharm International SA · NCT07035769 Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Phase 4 · Antwerp University Hospital · University Hospital, Antwerp · NCT05701241 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Antwerp University Hospital-Thoracic Oncology ( Site 0603) · Merck Sharp & Dohme LLC · NCT06077760 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · UZ Antwerpen · Gilead Sciences · NCT06051617 A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 2 · UZ Antwerpen · Janssen Research & Development, LLC · NCT04634552 Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Act
Phase 2/Phase 3 · University Hospital Antwerp (UZA) · KU Leuven · NCT06782412 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Antwerp University Hospital · Eli Lilly and Company · NCT07353931 Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDication
NA · Universitair Ziekenhuis Antwerpen · University Hospital, Antwerp · NCT06278844 A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Live
Phase 1 · Edegem · Bayer · NCT06764316 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · UZ Antwerpen · Janssen Research & Development, LLC · NCT06319820 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Universitair Ziekenhuis Antwerpen /ID# 239971 · AbbVie · NCT04928846 Use of Beetroot Juice to Protect Against Postoperative Ileus Following Colorectal Surgery: BEET IT Study
Phase 2 · Antwerp University Hospital · University Hospital, Ghent · NCT05133024 The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy
NA · Antwerp University Hospital · Universiteit Antwerpen · NCT06962579 A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of C
Phase 3 · Universitair Ziekenhuis Antwerpen /ID# 279334 · AbbVie · NCT07525206

Look up another city

Look up another condition